Affiliation:
1. UŞAK ÜNİVERSİTESİ
2. PAMUKKALE ÜNİVERSİTESİ
Abstract
Aim: The aim of this study was to compare the disease activity and functional status of individuals with Ankylosing Spondylitis (AS)
according to body mass index (BMI).
Material and Methods: This study, which was planned as a single-center cohort study, included 437 individuals with AS. Disease
activities were evaluated with the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and functional levels with the Bath
Ankylosing Spondylitis Functional Index (BASFI). Participants were categorized in 3 groups according to BMI data based on the criteria
of the World Health Organization: normal weight:20-24.9; overweight: 25-29.9; obese:≥30. One Way Anova Test, Kruskal Wallis Test,
Mann Whitney U test and Chi-Square Test were used to compare independent group differences. Linear regression models were used
to describe the relationship between BASDAI, BASFI (dependent variables) and BMI categories (independent variables). Univariate
regression analyses were performed (only one independent variable in the model).
Results: Among 437 patients with AS, 30.2% are normal weight, 39.5% are overweight and 30.2% are obese. Analysis results of data
between BMI groups; significant difference was in BASFI (p=0.001) in favor of the obese group. In binary group comparisons for BASFI;
there was a significant difference in favor of the obese group between normal and obese (p=0.002) and between overweight and obese
(p=0.001). Obese was significantly associated with higher BASFI score compared to the normal weight group without adjustment for
covariates (β:-0.37, 95%CI -0.66/-0.08, p=0.006). On the other hand, there was no association between BASDAI and obesity (β:-0.50,
95%CI -1.11/ 1.22, p:0.130).
Conclusion: The BMI of Turkish AS individuals in a single center cohort had no effect on disease activity, but obesity had a worse effect
on functional level.
Funder
This study did not receive any specific grant from funding agencies.
Publisher
Bulent Evcevit University
Reference28 articles.
1. 1. Haroon NN, Paterson JM, Li P, Inman RD, Haroon N. Patients
with ankylosing spondylitis have increased cardiovascular
and cerebrovascular mortality: a population-based study.
Ann Intern Med. 2015;163:409-416.
2. 2. Bengtsson K, Forsblad-d'Elia H, Lie E, Klingberg E, Dehlin
M, Exarchou S, Lindström U, Askling J, Jacobsson LTH. Are
ankylosing spondylitis, psoriatic arthritis and undifferentiated
spondyloarthritis associated with an increased risk of cardiovascular
events? A prospective nationwide population-based
cohort study. Arthritis Res Ther. 2017;19(1):102.
3. 3. Mathieu S, Soubrier M. Cardiovascular events in ankylosing
spondylitis: a 2018 meta-analysis. Ann Rheum Dis. 2019;78:
e57.
4. 4. Obesity and Overweight. World Health Organization. http://
www. who.int/mediacentre/factsheets/fs311/en/ Accessed
17.11.2021.).
5. 5. World Health Organization: Obesity and overweight: fact
sheet N0 311; 2012. http://www.who.int/mediacentre/factsheets/
fs311/en/index.html.